DEXTROSE
Gastric Emptying Time
Karaman Training and Research HospitalmixtureN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Gastric Emptying Time cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Semaglutide University Medical Centre Ljubljana | Phase 4 | BB |
METOCLOPRAMIDE Mater Misericordiae University Hospital | Phase 4 | BB |
gsk962040 GlaxoSmithKline | Phase 2 | B |
NORMAL HUMAN SERUM ALBUMIN Universiti Kebangsaan Malaysia Medical Centre | Phase 2 | CCC |
rq-00000010 Virginia Commonwealth University | Phase 1 | CC |
Lyn-057 Lyndra Inc. | Early Phase 1 | CC |
Sulfasalazine St. James's Hospital, Ireland | D | |
Octreotide Pamoate St. James's Hospital, Ireland | D |
Same molecule, other indications
DEXTROSE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →